Sanders Once Again Urges Biden Administration to Act to Lower Outrageous Price of Alzheimer's Treatment and Costly New Prescription Drugs
July 11, 2023
July 11, 2023
WASHINGTON, July 11 -- Sen. Bernie Sanders, I-Vermont, issued the following news release and letter on July 10, 2023:
Following the Food and Drug Administration's (FDA) full approval of the Alzheimer's drug Leqembi, Sen. Bernie Sanders (I-Vt.), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Monday sent a follow-up letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra once again urging the Biden Administration to act . . .
Following the Food and Drug Administration's (FDA) full approval of the Alzheimer's drug Leqembi, Sen. Bernie Sanders (I-Vt.), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Monday sent a follow-up letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra once again urging the Biden Administration to act . . .